Contingency Management Treatment Duration

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2013 by University of Connecticut Health Center
Sponsor:
Collaborator:
Information provided by (Responsible Party):
University of Connecticut Health Center
ClinicalTrials.gov Identifier:
NCT00732342
First received: August 7, 2008
Last updated: February 24, 2014
Last verified: December 2013
  Purpose

310 alcohol abusing or dependent patients beginning intensive outpatient day treatment at community-based clinics will be randomly assigned to one of four conditions: (a) standard treatment as usual (ST) at the clinic without contingency management (CM); (b) standard treatment with contingency management for 12 weeks with a 0.5 probability of winning prizes for each negative sample submitted; (c) standard treatment with contingency management for 24 weeks with a 0.34 probability of winning prizes for each negative sample submitted; or (d) standard treatment with contingency management for 24 weeks with a 0.5 probability of winning prizes for each negative sample submitted. We expect that contingency management will decrease alcohol use to a greater extent than non-contingency management treatment, and that availability of contingency management for 24 weeks may result in longer term benefits than 12 week exposure to contingency management. This study will be the first to evaluate the effects of probability of winning prizes on response to contingency management.


Condition Intervention Phase
Alcohol Abuse
Behavioral: Contingency Management
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Contingency Management Treatment Duration

Further study details as provided by University of Connecticut Health Center:

Primary Outcome Measures:
  • longest duration of negative breath samples submitted [ Time Frame: active phase and throughout follow-up phase ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • subjective reports of alcohol use [ Time Frame: baseline and each follow-up ] [ Designated as safety issue: No ]

Estimated Enrollment: 310
Study Start Date: February 2008
Estimated Study Completion Date: December 2014
Estimated Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: 1
Standard Treatment
Experimental: 2
Standard Treatment with Contingency Management for 12 weeks with a 0.5 probability of winning prizes for each negative sample submitted
Behavioral: Contingency Management
Prizes given for targeted behavior of abstinence
Experimental: 3
Standard Treatment with Contingency Management for 24 weeks with a 0.34 probability of winning prizes for each negative sample submitted
Behavioral: Contingency Management
Prizes given for targeted behavior of abstinence
Experimental: 4
Standard Treatment with Contingency Management for 24 weeks with a 0.5 probability of winning prizes for each negative sample submitted
Behavioral: Contingency Management
Prizes given for targeted behavior of abstinence

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • age > 18 years
  • current DSM-IV diagnosis of alcohol abuse or dependence
  • willing to sign informed consent and able to pass an informed consent quiz

Exclusion Criteria:

  • serious, uncontrolled psychiatric illness (e.g., acute schizophrenia, bipolar disorder, severe or psychotic major depression, or suicide risk) on the basis of history or medical examination
  • current DSM-IV diagnosis of opioid dependence
  • in recovery from pathological gambling
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00732342

Contacts
Contact: Ellen M Ciesielski, B.A. 860.679.4556 eciesielski@uchc.edu

Locations
United States, Connecticut
Prospect House Recruiting
Bridgeport, Connecticut, United States, 06604
Alcohol and Drug Recovery Centers, Inc. Recruiting
Hartford, Connecticut, United States, 06112
The Hospital of Central Connecticut at New Britain General Recruiting
New Britain, Connecticut, United States, 06050
Morris Foundation Completed
Waterbury, Connecticut, United States, 06702
United States, Massachusetts
Carlson Recovery Center Recruiting
Springfield, Massachusetts, United States, 01199
Sponsors and Collaborators
University of Connecticut Health Center
Investigators
Principal Investigator: Nancy M Petry, Ph.D. University of Connecticut Health Center
  More Information

No publications provided

Responsible Party: University of Connecticut Health Center
ClinicalTrials.gov Identifier: NCT00732342     History of Changes
Other Study ID Numbers: 08-053-2, P60AA003510
Study First Received: August 7, 2008
Last Updated: February 24, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by University of Connecticut Health Center:
Alcohol Abuse
Contingency Management
Treatment Duration

Additional relevant MeSH terms:
Alcoholism
Alcohol-Related Disorders
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders

ClinicalTrials.gov processed this record on August 26, 2014